Editas Medicine, Inc. SEC filings EDIT
Editas Medicine, Inc. has 727 filings in SEC EDGAR's recent list, going back to Aug 18, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Apr 28, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 9, 2026 | — |
| S-3 | Shelf registration | Aug 31, 2026 | — |
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| S-3MEF | Filing | May 26, 2026 | — |
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| POS AM | Filing | Mar 5, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| 424B5 | Prospectus supplement | Jun 14, 2023 | — |
| S-8 | Employee stock plan registration | Feb 22, 2023 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 424B5 | Prospectus supplement | May 14, 2021 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Jan 21, 2021 | — |
| 424B5 | Prospectus supplement | Jan 19, 2021 | — |
| 424B7 | Filing | Jan 11, 2021 | — |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| S-3ASR | Automatic shelf registration | Jun 23, 2020 | — |
| 424B5 | Prospectus supplement | May 15, 2020 | — |
| S-8 | Employee stock plan registration | Feb 26, 2020 | — |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| 424B7 | Filing | Jun 8, 2018 | — |
| S-3ASR | Automatic shelf registration | Mar 12, 2018 | — |
| S-8 | Employee stock plan registration | Mar 8, 2018 | — |
| 424B7 | Filing | Jan 22, 2018 | — |
| 424B7 | Filing | Jan 12, 2018 | — |
| 424B7 | Filing | Jan 4, 2018 | — |
| S-3ASR | Automatic shelf registration | Dec 22, 2017 | — |
| 424B5 | Prospectus supplement | Dec 7, 2017 | — |
| 424B5 | Prospectus supplement | Dec 5, 2017 | — |
| 424B7 | Filing | Sep 18, 2017 | — |
| 424B7 | Filing | Aug 14, 2017 | — |
| 424B7 | Filing | Aug 4, 2017 | — |
| S-3/A | Filing | Mar 28, 2017 | — |
| 424B5 | Prospectus supplement | Mar 17, 2017 | — |
| 424B5 | Prospectus supplement | Mar 15, 2017 | — |
| S-3 | Shelf registration | Mar 8, 2017 | — |
| S-8 | Employee stock plan registration | Mar 3, 2017 | — |
| S-3 | Shelf registration | Mar 3, 2017 | — |
| S-8 | Employee stock plan registration | Nov 10, 2016 | — |
| S-8 | Employee stock plan registration | Feb 3, 2016 | — |
| 424B1 | Filing | Feb 3, 2016 | — |
| S-1/A | Amended registration statement | Jan 25, 2016 | — |
| S-1 | Registration statement | Jan 4, 2016 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- EDIT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1650664
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.